![](/images/graphics-bg.png)
XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications
Joint Authors
Eltanamly, Rasha M.
Osman, A. A.
Galal, Ahmed
Bilgic, Alper
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-03-01
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Purpose.
To evaluate gel microstent (XEN, Aquesys, Inc) for treatment of primary open angle glaucoma (POAG).
Methods.
In this prospective interventional study, 13 eyes with POAG underwent XEN implantation with subconjunctival mitomycin-C.
Of those eyes, 3 were pseudophakic and 10 underwent simultaneous phacoemulsification and XEN.
Patients had uncontrolled IOP, had intolerance to therapy, or had maximal therapy but undergoing cataract extraction.
Follow-up visits included IOP, number of medications, vision, and complications and lasted for 1 year.
Complete success was defined as IOP reduction ≥20% from preoperative baseline at 1 year without any glaucoma medications while partial success as IOP reduction of ≥20% at 1 year with medications.
Results.
IOP dropped from 16 ± 4 mmHg pre-op to 9 ± 5, 11 ± 6, 12 ± 5, 12 ± 4, and 12 ± 3 mmHg at 1 week, 1, 3, 6, and 12 months (p=0.004, 0.026, 0.034, 0.01, and 0.01, Wilcoxon Signed Ranks) consecutively.
BCVA (LogMAR) was 0.33 ± 0.34 and improved to 0.13 ± 0.11 at 1 year.
Mean number of medications dropped from 1.9 ± 1 preoperatively to 0.3 ± 0.49 (p=0.003) at 1 year.
42% of eyes achieved complete success and 66% qualified success.
Complications included choroidal detachment in 2 eyes, and implant extrusion in 1 eye, and 2 eyes underwent trabeculectomy.
Conclusion.
XEN implant is an effective surgical treatment for POAG, with significant reduction in IOP and glaucoma medications at 1 year follow-up.
American Psychological Association (APA)
Galal, Ahmed& Bilgic, Alper& Eltanamly, Rasha M.& Osman, A. A.. 2017. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications. Journal of Ophthalmology،Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1185032
Modern Language Association (MLA)
Galal, Ahmed…[et al.]. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications. Journal of Ophthalmology No. 2017 (2017), pp.1-5.
https://search.emarefa.net/detail/BIM-1185032
American Medical Association (AMA)
Galal, Ahmed& Bilgic, Alper& Eltanamly, Rasha M.& Osman, A. A.. XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications. Journal of Ophthalmology. 2017. Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1185032
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1185032